Why does Novartis work in global health?
For more than eight decades, Novartis has taken on the toughest challenges in global health. And as global health is under pressure from threats like climate change and the rising burden of chronic diseases, drug resistance and declining donor funding, we are going further.
The Novartis Global Health unit is a sustainable business that deploys our skills as an innovative medicines company for patients living in low- and middle-income countries. We reach about 30 million people every year.
In 2024 and again in 2026, we ranked No. 1 in the Access to Medicines Index for our commitment to improving the lives of patients around the world.
Together with our partners, we deliver the next generation of innovation for malaria and neglected tropical diseases, and find new ways to bring innovative therapies for conditions like heart disease and cancer to communities beyond the reach of conventional models.
We are in the business of innovation, against the odds.
